Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...

Alcon (ALC) announced it terminated its agreement to acquire STAAR Surgical (STAA). “Throughout this process we remained ...

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

Adds analyst comment, updates shares. STAAR Surgical (STAA) fell 8.3% as it plans to terminate its sale to Alcon (ALC) after ...

Alcon ( (CH:ALC)) has provided an update. On January 6, 2026, Alcon terminated its definitive merger agreement to acquire STAAR Surgical Company, originally announced on August 5, 2025, signaling a ...

Key Insights Alcon's estimated fair value is CHF101 based on 2 Stage Free Cash Flow to Equity Alcon's CHF64.56 ...

It appears that Staar Surgical Co.'s proposed $1.6 billion merger with Alcon AG has been scrapped as Starr shareholders voted ...

CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.